Vol 13, No 3 (June 30, 2024): Chinese Clinical Oncology

Review Article

Immunotherapy for patients with thyroid cancer: a comprehensive appraisal
Alfredo Pinheiro Neto, Henrique Luca Lucchesi, Victor Alexandre dos Santos Valsecchi, Laura Sterian Ward, Lucas Leite Cunha
Discrepancy between recommendations regarding hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer management: a narrative review
Szymon Piątek, Elżbieta Sarnowska, Joanna Kacperczyk-Bartnik, Halszka Kołaczkowska, Piotr Sobiczewski, Mariusz Bidziński
Updates in the role of the tumor microenvironment cellular crosstalk and genetic signatures in diffuse large B-cell lymphoma: a narrative review
Shima Rastegar, Michael Kallen, David Ilan Suster
Metformin as a therapeutic tool for resistant hematological malignancies: a literature review
Graziele Silva Paz, Janaina Fernandes
Safety and tolerability of radiotherapy in combination with systemic targeted therapies for treatment of hepatocellular carcinoma: a narrative review
Madeleine L. Hall, Sweet Ping Ng, Umbreen Hafeez, Niall Tebbutt, Marie Sinclair, Farshad Foroudi, Michael Chao, Richard Khor
Update on management of pancreatic cancer: a literature review
Eric C. H. Lai, Aidan K. Y. Ung

Case Report

Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review
Luis Posado-Domínguez, Luis Figuero-Pérez, Alejandro Olivares-Hernández, Luis Chinchilla-Tábora, Patricia Antunez-Plaza, Raquel Rivas-Hernández, María Martín-Galache, Juan Carlos Redondo González, Emilio Fonseca Sánchez
A case of pulmonary tuberculosis that developed during nivolumab and ipilimumab treatment for pulmonary adenocarcinoma that recurred two months after completion of anti-tuberculous treatment
Satoshi Hirano, Hidekazu Takahashi, Sukeyuki Nakamura, Kousei Matsuda, Rintaro Ishikawa, Kei Tamura, Kohei Shikano, Tetsuo Fujita, Hiroyuki Amano, Makoto Nakamura